• The Use of ATMPs in Oncology Clinical Trials

  • May 21 2024
  • Duración: 20 m
  • Podcast

The Use of ATMPs in Oncology Clinical Trials  Por  arte de portada

The Use of ATMPs in Oncology Clinical Trials

  • Resumen

  • How can phase I studies with ATMPs address unmet needs in oncology and what are the challenges? In this episode of Conversations in Drug Development, Dr Katherine Bowen is joined by Pharmaceutical Physician, Dr Harriet Gray Stephens, to delve into the complexities of phase I oncology studies involving advanced therapy medicinal products (ATMPs). Join us as we discuss the unique challenges of ATMPs, such as their different benefit-risk profiles compared to traditional therapies, and the need for innovative dose escalation and efficacy evaluation methods as well as the potential of ATMPs to meet unmet needs in cancer treatment.

    Más Menos
activate_primeday_promo_in_buybox_DT

Lo que los oyentes dicen sobre The Use of ATMPs in Oncology Clinical Trials

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.